Skip to main content
. 2012 May 24;7(8):1310–1319. doi: 10.2215/CJN.00260112

Figure 2.

Figure 2.

Proportion of patients with donor specific antibodies (DSAs) after a systematic or clinically indicated allograft nephrectomy. (A) Proportion of patients with anti–human leukocyte antigen (anti-HLA) class I + II DSAs regarding the indication of allograft nephrectomy. (B) Proportion of anti-HLA class I DSAs. (C) Proportion of anti-HLA class II DSAs. GN, graft nephrectomy.